Status:
COMPLETED
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Sanofi
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
* Whether a combination of three therapies - metformin and a sulfonylurea plus Exubera, an investigational drug, controls your diabetes at least as much as a triple combination therapy of metformin an...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Currently treated and on a stable doses of drugs for the preceding two (2) months
Exclusion
- Type 1 Diabetes
- Smoking
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
626 Patients enrolled
Trial Details
Trial ID
NCT00150410
Start Date
January 1 2003
End Date
June 1 2007
Last Update
October 31 2008
Active Locations (119)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Mesa, Arizona, United States, 85205
2
Pfizer Investigational Site
Phoenix, Arizona, United States, 85012
3
Pfizer Investigational Site
Tucson, Arizona, United States, 85715
4
Pfizer Investigational Site
Searcy, Arkansas, United States, 72143